Results 51 to 60 of about 384,964 (298)
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa +8 more
wiley +1 more source
Innovation by Retail Store Salespersons:
Maketingu JanaruThis paper proposes a new value for retail store salespersons in response to the low productivity of the Japanese retail industry compared with that of the United States. The new value is innovation by retail store salespersons.
Yuya Watanabe, Hidehiko Nishikawa
doaj +1 more source
Nordic Journal of Social Research, 2020 Introduction: There has been an increased focus on the search for innovative ways to use technology to improve services among many public welfare services. However, this focus has been less apparent among municipal substance abuse follow-up and aftercare
Vidar Bakkeli +1 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Children with acute lymphoblastic leukemia (ALL) are at risk of severe outcomes from SARS‐CoV‐2 (SCV2). In the post‐pandemic context, where most children have been infected with SCV2, there are limited data on whether vaccination remains beneficial in children with ALL.
Janna R. Shapiro +11 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background An internal tandem duplication in the gene encoding Fms‐like tyrosine kinase 3 (FLT3‐ITD) is associated with high relapse risk and poor prognosis in acute myeloid leukemia (AML) and plays a crucial role in treatment decisions. Measurable residual disease (MRD) analysis of FLT3‐ITD during and after treatment has shown prognostic ...
Sofie Johansson Alm +11 more
wiley +1 more source
Empowering lead users: Kenya's three-part formula for fintech innovation success
Serbian Journal of ManagementLead user innovation is one of the key factors which define new product development and market success, but the characteristics of user innovators in emerging markets are still not explored enough.
Geoffrey Otieno, Ruth Kiraka
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Claudin‐6 has emerged as a promising immunotherapeutic target, yet protein‐level data in atypical teratoid/rhabdoid tumors (AT/RTs) have been inconsistent. We analyzed 36 well‐characterized AT/RT samples and found membranous claudin‐6 protein expression in 58% of cases, with striking enrichment in the molecular subgroup AT/RT‐TYR (100%) and ...
Victoria E. Fincke +4 more
wiley +1 more source
Potential for the Development of User Innovation by Salespersons in Stores
Maketingu Janaru, 2019 Many Japanese retailers consider that the development of unique own-brand products is important in the current fierce competition between retailers. In previous research, the volume of sales and consumer information generated at each store have become ...
Nobutoshi Shimizu
doaj +1 more source
Model of Social Influence in Analysis of Socio-engineering Attacks
Управленческое консультирование, 2021 The purpose of this study is to study the modernization of the model of an attacker’s social engineering attack on a user, taking into account a wider range of factors influencing the success of a social engineering attack associated with the principles ...
T. V. Tulupieva +2 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Wilms tumor (WT) treatment imposes a significant time burden on patients and their families. Time toxicity is a patient‐centered metric that quantifies the burden of healthcare interaction. We sought to define time toxicity in the first year after diagnosis of WT and hypothesized that it would increase as tumor stage and treatment ...
Caleb Q. Ashbrook +6 more
wiley +1 more source